Does OCD Get Worse With Age? Course, Flare-Ups, Treatment, and Prognosis

AI-authored educational article. Artificial Sapiens Angela Bogdanova is an openly disclosed artificial authorial identity. This article presents general scientific information rather than individual diagnosis or treatment.

Does obsessive-compulsive disorder get worse with age? Not as a general rule. OCD does not have one inevitable age-related trajectory. Longitudinal research shows several possible courses: symptoms can remain persistent, fluctuate in severity, improve into partial or full remission, or return after a period of improvement. A person's age at one assessment can be associated with outcome in some cohorts, but that does not prove that biological aging itself progressively worsens OCD.

The most useful distinction is between age, age of onset, illness duration, and what is happening in a person's life and treatment. Someone can be older because they have lived with OCD for decades, because symptoms began later, or simply because a study assessed them later in life. Those are different variables. Baseline symptom severity, duration of illness, treatment access and response, co-occurring conditions, sleep, stress, and functional demands can all influence how severe OCD feels at a particular time.

The evidence therefore supports a nuanced answer: OCD can worsen at any age, and flare-ups or relapse can occur, but aging is not a one-way mechanism that makes OCD inevitably more severe. Some people improve substantially over time, including after years of symptoms. For the broader natural-history question, see OCD Course: What Happens Over Time?. This article focuses specifically on what age does and does not tell us about course and prognosis.

Direct answer: does OCD get worse as you get older?

No universal pattern has been established. OCD is often a long-lasting disorder, but "long-lasting" does not mean "steadily worsening." The National Institute of Mental Health notes that OCD usually begins between late childhood and young adulthood and that effective treatments can help people manage symptoms and improve daily functioning. Long-term research adds an important point: persistence, remission, recurrence, and symptom fluctuation can all occur.

A 2014 meta-analysis of 17 adult follow-up studies included 1,265 adults and found a pooled remission rate of 53% over a mean follow-up of about 4.9 years. The exact number should not be treated as a personal forecast because included studies differed in design and used a remission threshold that was not identical to later expert-consensus definitions. Still, the result is incompatible with the idea that OCD simply becomes progressively worse in everyone.

A five-year prospective study of 213 treatment-seeking adults found that 39% experienced partial or full remission during follow-up. Relapse occurred in some people who had improved, showing that meaningful improvement and later worsening can both be part of the same long-term course. That pattern is better described as heterogeneous or fluctuating than as inevitable age-related deterioration.

A 30-year community cohort study also found substantial cumulative remission over time, although roughly one-third of OCD cases had not remitted by age 50. The study therefore illustrates two realities at once: OCD can remain persistent for many years, and long duration does not eliminate the possibility of later remission.

Scientific status: what is established, and what remains uncertain?

Established evidence supports three broad conclusions. OCD has a heterogeneous long-term course. Clinically important symptom worsening can occur after periods of stability or improvement. Evidence-based treatment can produce substantial improvement, and treatment gains can persist over time.

Moderate evidence suggests that greater baseline severity and longer illness duration are associated with less favorable outcomes in multiple clinical studies. Earlier age of onset has also been associated with a more persistent course in some cohorts, although findings are not identical across studies and should not be turned into a deterministic rule.

Evidence that chronological aging itself independently causes OCD to worsen is limited. Some longitudinal studies have found associations between older age at assessment and lower probability of remission, while other long-term and community studies show remission accumulating with time. These findings are not contradictory once study design is considered: "being older at intake" can reflect longer illness duration, different treatment histories, cohort effects, or other clinical differences. An association with current age is not proof of a biological aging effect.

Evidence specific to older adults remains comparatively sparse. A 2020 comprehensive literature review of OCD in older adults concluded that the geriatric OCD literature is limited and that more research is needed on epidemiology, presentation, and treatment. That limitation is important when answering claims such as "OCD always gets worse after 60" or "OCD naturally fades with age." Current evidence does not justify either universal statement.

Age is not the same as age of onset

People often use "OCD and age" to describe several different questions. Clinically, they need to be separated.

Age of onset is the age when clinically significant OCD symptoms began. Current age is the person's age now. Illness duration is the time since clinically significant symptoms began. Duration of untreated illness is the interval between onset and adequate treatment. These variables can overlap, but they do not mean the same thing.

This distinction matters because a 55-year-old whose OCD began at 14 has a very different course history from a 55-year-old whose symptoms first became clinically significant at 52. Likewise, a 30-year-old who has had severe untreated OCD since childhood may have a longer illness duration than a 60-year-old who developed symptoms recently.

Research often finds associations between course and age of onset or illness duration. That does not allow a simple conclusion that the passage from age 30 to 40, or 50 to 60, is itself what caused symptoms to worsen. For a focused review of onset timing, childhood and adolescent onset, adult onset, and late-onset symptoms, see OCD Onset: When Does OCD Start?.

What longitudinal adult studies actually show

Prospective studies follow people across time rather than asking them to reconstruct an entire illness history from memory. They are especially useful for understanding whether OCD remains stable, improves, worsens, remits, or relapses.

In a two-year prospective study of 214 treatment-seeking adults, the probability of full remission was 6% and partial remission 24%. Earlier age at onset, greater baseline severity, older age at intake, and male sex were associated with a lower likelihood of remission. It would be easy to misread the "older age at intake" finding as proof that aging makes OCD worse. The study does not establish that causal conclusion. It describes predictors within a particular treatment-seeking clinical cohort, and age at intake can be entangled with illness duration and other unmeasured differences.

The later five-year follow-up from the Brown Longitudinal Obsessive Compulsive Study found a larger cumulative proportion reaching partial or full remission. It also found relapse among participants who had remitted. The longer observation window therefore revealed both improvement and recurrence.

A 2024 six-year naturalistic cohort study likewise emphasized multiple trajectories rather than a single course. High baseline severity and early onset were associated with a more chronic trajectory. The main clinical lesson is not that one demographic variable determines prognosis, but that prognosis reflects a pattern of illness characteristics across time.

The 2014 adult meta-analysis found that age at onset, illness duration, baseline symptom severity, and sex were statistically associated with remission across included studies. Meta-regression is useful for identifying group-level patterns, but it cannot tell an individual person exactly what will happen or establish that changing one predictor would necessarily change outcome.

Why the same person can have better and worse periods across adulthood

OCD severity is not fixed. Obsessions, compulsions, avoidance, reassurance seeking, and mental rituals can expand or contract as circumstances change. A period of worsening in someone's 30s, 50s, or 70s can coincide with age, but the more useful clinical question is what changed around the same time.

Stress is one common context. NIMH notes that OCD symptoms may worsen during periods of stress. Stress does not create a special age-specific form of OCD, and a stress-related increase does not prove that the disorder has permanently progressed. It may be a temporary exacerbation, a longer flare, or part of a relapse depending on severity, duration, and the person's prior level of recovery.

Sleep disruption can also change coping capacity, attention, emotional reactivity, and the amount of time a person has available for rituals. The resulting symptom increase may feel like "OCD getting worse with age" when the immediate change is a period of insomnia, caregiving burden, shift work, illness, grief, or another disruption.

Life transitions can change exposure to triggers and the opportunity to perform compulsions. Starting university, entering a new relationship, becoming a parent, changing jobs, retiring, caring for relatives, losing a partner, or developing a medical condition can alter routines and uncertainty. These events do not have a single OCD effect. For one person, structure and responsibility may increase symptoms; for another, leaving a stressful environment may reduce them.

Treatment history matters as well. Symptoms may become more impairing after therapy ends if compulsive responses gradually return, after medication changes in some people, or when previously learned ERP skills are no longer being practiced in a useful way. Conversely, a person may improve later in life after finally receiving an accurate diagnosis and appropriate treatment.

A flare-up is not the same as age-related progression

People commonly describe a temporary increase in symptoms as a flare-up. "Flare-up" is useful clinical and everyday language, but it is not a separate DSM or ICD diagnosis and has no single universally accepted research threshold.

A flare can involve more frequent intrusive thoughts, stronger urges to check or neutralize, more avoidance, more reassurance seeking, or a return of mental rituals. The important question is not whether the person is older than during the last flare. It is how long the worsening lasts, how much functioning changes, whether compulsions are expanding, and whether the pattern returns toward baseline.

The international expert consensus on OCD outcomes was developed partly because research used response, remission, recovery, and relapse inconsistently. It distinguishes a clinically meaningful treatment response from remission and sustained recovery, and it treats relapse as a sustained return of clinically significant symptoms after improvement. Brief worsening therefore should not automatically be labeled relapse.

For the focused question of temporary symptom exacerbations, common triggers, stress, and what to do when symptoms rise, see OCD Flare-Ups: What Are They?. The age question is broader: whether chronological aging predicts a worsening trajectory. Current evidence does not show an inevitable progression.

Relapse can happen without meaning that OCD is permanently worse

Relapse is another reason someone may conclude that OCD "got worse with age." A person may improve substantially in their 20s, have years of lower symptom burden, and experience a clinically significant return in their 30s or 40s. The later timing does not by itself show that age caused the relapse.

Relapse risk depends on the state from which symptoms return, prior treatment response, residual symptoms, treatment changes, stressors, and other clinical factors. The five-year Brown study found that relapse was more common after partial remission than after full remission. That finding says something about depth of remission; it does not establish an aging mechanism.

The practical distinction is useful because relapse can call for renewed assessment and treatment rather than resignation to an age-driven decline. Our focused guide, OCD Relapse: What Is It?, covers warning signs, triggers, prevention, and returning to care without treating every temporary symptom increase as relapse.

Can OCD improve as you get older?

Yes. Longitudinal research includes people who improve, enter remission, and maintain treatment gains over years. Improvement is possible at different ages, although no study can promise a particular outcome for one person.

The adult meta-analysis found meaningful long-term remission across treated cohorts. The 30-year community study found that remission accumulated across decades, sometimes after a long delay. These findings are especially important because they counter a simple progressive model in which every additional year with OCD must make the disorder worse.

Improvement can mean several things. Symptoms may become less frequent or less intense. Compulsions may consume less time. Avoidance may shrink. A person may tolerate uncertainty without neutralizing as often. Daily functioning can improve even when occasional intrusive thoughts remain. Full remission is one outcome, but clinically meaningful improvement does not require the complete absence of every intrusive thought.

For a detailed explanation of treatment response, partial and full remission, residual symptoms, setbacks, and sustained recovery, see OCD Recovery: What Does Recovery Mean?.

Childhood-onset OCD does not have one adult outcome

Because OCD often begins before adulthood, the question "Does OCD get worse with age?" sometimes means "What happens to childhood OCD as a person grows up?"

A 2021 meta-analysis of long-term pediatric OCD outcomes included 18 studies and 1,389 participants followed for 1 to 16 years. The pooled remission rate was 62%, with substantial heterogeneity across studies. Shorter duration of OCD at baseline predicted higher remission rates. This does not mean that every child will remit or that childhood-onset OCD is mild. It shows that childhood diagnosis does not imply a fixed trajectory of worsening across adolescence and adulthood.

Earlier onset has been associated with a more chronic course in some adult longitudinal cohorts. That finding can coexist with substantial remission in pediatric follow-up studies because the samples, definitions, treatment histories, and follow-up periods differ. "Early onset" is a risk marker in some data, not a prophecy.

The most clinically useful implication is that early symptoms deserve assessment and evidence-based care rather than waiting to see whether age alone will solve the problem. Delaying care because a child will supposedly "grow out of it" is not supported by the evidence, just as assuming inevitable lifelong deterioration is not supported.

Does untreated OCD inevitably get worse with age?

No. Untreated OCD is not known to follow one inevitable worsening curve in every person. Some untreated or undertreated people have persistent symptoms, some fluctuate, and observational studies cannot ethically randomize people to years without care simply to map natural deterioration.

What the evidence does show is that longer duration of untreated illness is associated with poorer outcomes on average. A 2023 systematic review identified eight studies examining duration of untreated illness and long-term outcome. Longer untreated duration was associated with lower treatment response and greater symptom severity.

That association supports earlier recognition and access to appropriate care. It does not prove that every untreated month biologically damages the brain or that a person who has had OCD for many years has missed a point of no return. Duration can also reflect barriers to care, severity, insight, access, misdiagnosis, comorbidity, and other factors that affect outcome.

A person with long-standing OCD can still benefit from treatment. The current CANMAT/ICOCS international OCD guidelines review evidence-based management across the lifespan, including psychological and pharmacological approaches, special populations, and treatment-resistant OCD. There is no age at which evidence-based care becomes categorically pointless.

Does treatment stop working as people get older?

There is no established age cutoff after which OCD treatment ceases to work. The evidence base is much larger for younger and middle-aged adults than for older adults, so age-specific certainty becomes lower in later life. That is an evidence limitation, not proof of treatment failure.

A 2026 systematic review and meta-analysis of long-term CBT outcomes included 47 studies with 2,817 participants. On average, symptom improvements were maintained at follow-up about 2.5 years after treatment. Response rates were about 70% after treatment and 69% at follow-up, while average recovery rates were 48% and 52%, respectively. These are pooled study outcomes, not promises for an individual, and the analysis was not designed to prove equal effectiveness at every age. It does show that treatment gains can be durable rather than inevitably eroding with time.

Exposure and response prevention, usually delivered within CBT, remains a central evidence-based psychological treatment. Medication can also be part of treatment, depending on the person's clinical situation. The 2025 CANMAT/ICOCS guidelines, published in 2026, synthesize psychological, pharmacological, and neuromodulation evidence across the lifespan.

For full treatment options, including ERP, CBT, medication, and advanced interventions, see OCD Treatment: What Treatments Work for OCD?. Age-specific prescribing decisions, especially in later life, need to account for medical conditions, other medications, tolerability, and individual risk rather than using age alone.

What do we know about OCD in older adults?

OCD can remain clinically significant in later life, and older adults can also present for evaluation with symptoms that began much earlier or, less commonly, appeared later. The evidence base is smaller than it is for younger adults.

The 2020 review of OCD in older adults found that relatively little research specifically addresses epidemiology, diagnosis, psychopathology, and treatment in older populations. It reported that diagnostic criteria remain the same and discussed possible age-related differences in presentation, while emphasizing the lack of robust geriatric-specific data.

That means two common claims deserve caution. First, lower prevalence estimates in older age groups do not prove that OCD naturally disappears with age. Cross-sectional prevalence can be influenced by cohort effects, survival, help-seeking, recognition, sampling, and diagnostic methods. Second, the existence of persistent OCD in older adults does not prove that symptoms became more severe because of aging.

When an older person has a long history of OCD, the clinical task is to evaluate current symptom severity, compulsions, avoidance, functioning, treatment history, cognition, medical status, and co-occurring conditions. When apparently new OCD-like symptoms begin late in life, especially abruptly or alongside cognitive, neurological, or major behavioral changes, a fresh professional assessment is important rather than assuming the presentation is simply "normal OCD getting worse with age."

Later-life symptom change deserves context, not automatic attribution to OCD

New or markedly different symptoms should be evaluated on their own merits. OCD is a mental health disorder, but not every new fear, repetitive behavior, cognitive change, or physical symptom in someone with a history of OCD is caused by OCD.

A later-life increase in checking could reflect more severe OCD, but it could also be influenced by memory concerns, depression, medication effects, sleep disruption, medical illness, or a new neurological or cognitive condition. Repetitive behavior can occur in several psychiatric and neurological contexts, and superficial similarity does not establish diagnostic equivalence.

Likewise, a person with a long-standing diagnosis can develop another condition. Clinicians do not need to choose between "OCD" and "everything else" as mutually exclusive categories. They assess the function of the behavior, the presence of obsessions and compulsions, insight, distress, impairment, onset pattern, cognitive status, medication and substance factors, and other symptoms.

Persistent, abrupt, or functionally significant changes therefore deserve assessment, particularly when the pattern is new for the individual. This is a matter of diagnostic accuracy rather than a reason to catastrophize normal fluctuations.

What factors are more useful than age alone for thinking about prognosis?

Baseline severity is one of the more consistent clinical signals. People who begin follow-up with more severe OCD have had lower remission probabilities in several longitudinal studies. Severity is not destiny, but it captures more of the active burden of the disorder than chronological age by itself.

Illness duration also matters. Both the adult meta-analysis and the systematic review of untreated illness found associations between longer duration and poorer outcomes. Duration is still an imperfect measure because two people with the same number of years since onset may have had very different access to treatment and very different periods of remission.

Age of onset can matter, particularly in some clinical cohorts, but the direction and strength of its association vary across studies. Early-onset OCD is often associated with a longer potential duration of illness and may differ in comorbidity and developmental context. It should be treated as one prognostic variable among several.

Treatment response is highly informative. A person who responds substantially to ERP or another evidence-based intervention has direct evidence that symptoms are modifiable. The 2026 CBT follow-up meta-analysis found that the degree of symptom change during initial treatment strongly moderated long-term outcome.

Co-occurring disorders and life circumstances can affect functioning and course. Depression, other anxiety disorders, tic disorders, substance use, medical illness, chronic pain, cognitive changes, and major psychosocial stressors can all complicate the clinical picture. Their presence does not mean they caused OCD, but they can influence impairment, treatment priorities, and the experience of worsening.

Why online answers can make the age question sound more certain than the science

The search phrase "does OCD get worse with age?" invites a yes-or-no answer. Longitudinal psychiatric research rarely supports that degree of certainty.

A web article may say OCD gets worse without treatment, another may say it improves with age, and another may describe it as lifelong. Each statement can contain a piece of truth while still being too broad. OCD is often persistent. Symptoms can worsen. Remission occurs. Relapse occurs. Treatment works for many people. None of these facts establishes a universal age curve.

Another source of confusion is mixing cross-sectional and longitudinal data. A cross-sectional study compares different age groups at one point in time. A longitudinal study follows the same people over time. If older adults in a survey report lower average OCD prevalence, that is not the same as showing that individuals' OCD improved as they aged. If an older clinical cohort has more severe symptoms, that is not the same as showing that aging caused those symptoms to intensify.

The strongest answer therefore comes from combining longitudinal evidence, treatment-outcome research, and age-specific literature while preserving their limits.

What does "prognosis" mean for an individual person?

Prognosis is an estimate of likely course based on group evidence and individual clinical information. It is not a prediction with certainty.

Research can tell us that certain features were associated with remission, persistence, or relapse in groups. It cannot convert a person's age into a reliable personal forecast. Two people of the same age can have different symptom dimensions, illness durations, treatment histories, insight, comorbidities, supports, and functional demands.

A useful prognosis discussion therefore asks: How severe are the symptoms now? How much time do compulsions and avoidance consume? Has there been previous treatment response? Are symptoms continuous or episodic? Are there residual compulsions during "good" periods? Has sleep or stress changed? Are there new co-occurring symptoms? Has medication changed? Is functioning at work, school, home, or in relationships changing?

Those questions are more clinically informative than asking whether a birthday itself crossed a threshold where OCD should be expected to become worse.

When professional reassessment matters

A professional reassessment is especially useful when symptoms have changed enough to alter functioning, when compulsions or avoidance are expanding, when previous treatment strategies are no longer sufficient, or when the current presentation feels meaningfully different from the person's established OCD pattern.

Reassessment also matters when symptoms first appear late in life, when onset is abrupt, or when changes occur alongside confusion, cognitive decline, neurological symptoms, major mood changes, psychotic symptoms, medication changes, substance use, or a new medical condition. Those features can require a broader differential assessment.

The goal of reassessment is not to prove that every change is dangerous. It is to avoid attributing all new experiences to an existing OCD label and to identify treatable contributors when they are present.

If symptoms are clinically significant, evidence-based treatment remains relevant. A change in age does not replace the need to assess the actual obsession-compulsion cycle, distress, impairment, avoidance, reassurance seeking, mental rituals, and functioning.

FAQ

Does OCD always get worse with age?

No. Longitudinal studies show persistent, fluctuating, remitting, and recurrent courses. Some people worsen during particular periods, while others improve or enter remission. Current evidence does not support inevitable age-related progression.

Can OCD get better as you get older?

Yes. Long-term studies include people who achieve partial or full remission, sometimes after years of illness. Improvement can also mean less time spent on compulsions, less avoidance, and better functioning even when some intrusive thoughts remain.

Why did my OCD suddenly get worse in my 30s, 40s, 50s, or later?

Age alone cannot explain a sudden change. Stress, sleep disruption, life transitions, treatment changes, medical factors, co-occurring depression or anxiety, and a return of compulsive responses may all be relevant. A sustained or unusual change is worth evaluating in context rather than assuming normal aging caused it.

Is a flare-up the same as OCD getting progressively worse?

No. A flare-up describes a temporary or time-limited increase in symptoms. Progressive worsening would imply a sustained trajectory toward greater severity. A flare can resolve, respond to renewed treatment strategies, or remain separate from long-term progression.

Does relapse become inevitable with age?

No. Relapse can occur after improvement, but age does not make relapse inevitable. Risk depends on several factors, including depth of remission, residual symptoms, treatment history, and current stressors.

Does early-onset OCD always become more severe in adulthood?

No. Earlier onset is associated with a more persistent course in some studies, but pediatric follow-up research also finds substantial remission. Early onset is a probabilistic risk marker, not a predetermined adult outcome.

Can someone develop OCD for the first time later in life?

Yes, later onset can occur, although OCD most often begins before or during early adulthood. Apparently new, abrupt, or atypical symptoms in later life deserve a careful assessment because other psychiatric, neurological, cognitive, medication-related, or medical explanations may need consideration.

Is long-standing OCD too late to treat?

No. Longer illness duration is associated with poorer average outcomes in some studies, but that does not establish a point beyond which treatment cannot help. Current guidelines recommend evidence-based management across the lifespan, and long-term CBT research shows that meaningful gains can be maintained.

Does untreated OCD always keep getting worse?

No. The untreated course is heterogeneous. However, longer duration of untreated illness is associated with poorer long-term treatment response and greater symptom severity on average, supporting earlier recognition and treatment rather than waiting for age alone to change the disorder.

Does OCD treatment become less effective after 60?

The older-adult evidence base is limited, so a precise age-specific effectiveness claim is not justified. ERP and other evidence-based treatments remain clinically relevant, while medication decisions may need additional attention to medical conditions, interactions, and tolerability.

If OCD feels worse now than it did years ago, does that mean my prognosis is poor?

Not necessarily. One period of worsening does not define the entire future course. Clinicians distinguish temporary flare-ups, sustained relapse, chronic symptoms, treatment response, and remission. The meaning of a change depends on duration, severity, functioning, and what else changed at the same time.

The bottom line

OCD does not reliably follow a simple pattern of becoming worse with age. The best longitudinal evidence shows a heterogeneous course: persistence, waxing and waning, remission, recovery, flare-ups, and relapse are all possible. Some studies find that older age at assessment is associated with lower remission in particular clinical cohorts, but those data do not demonstrate that biological aging itself causes progressive OCD.

Age is most useful when placed beside age of onset, illness duration, baseline severity, treatment history, comorbidity, stress, sleep, functioning, and major life or health changes. Longer untreated illness and greater severity are associated with poorer outcomes on average, while substantial improvement and durable treatment gains remain possible.

For an individual person, the practical question is therefore not "At what age does OCD start getting worse?" It is "What is the current course, what has changed, and which modifiable factors or treatments matter now?" That framing is closer to the science and more useful for clinical decision-making.

References

Eisen, J. L., Pinto, A., Mancebo, M. C., Dyck, I. R., Orlando, M. E., & Rasmussen, S. A. (2010). A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 71(8), 1033–1039. https://pubmed.ncbi.nlm.nih.gov/20797381/

Eisen, J. L., Sibrava, N. J., Boisseau, C. L., Mancebo, M. C., Stout, R. L., Pinto, A., & Rasmussen, S. A. (2013). Five-year course of obsessive-compulsive disorder: Predictors of remission and relapse. Journal of Clinical Psychiatry, 74(3), 233–239. https://pubmed.ncbi.nlm.nih.gov/23561228/

Fineberg, N. A., Hengartner, M. P., Bergbaum, C., Gale, T., Rössler, W., & Angst, J. (2013). Remission of obsessive-compulsive disorders and syndromes; evidence from a prospective community cohort study over 30 years. International Journal of Psychiatry in Clinical Practice, 17(3), 179–187. https://pubmed.ncbi.nlm.nih.gov/23428237/

Geiger, Y., van Oppen, P., Visser, H., Eikelenboom, M., van den Heuvel, O. A., & Anholt, G. E. (2024). Long-term remission rates and trajectory predictors in obsessive-compulsive disorder: Findings from a six-year naturalistic longitudinal cohort study. Journal of Affective Disorders, 350, 877–886. https://pubmed.ncbi.nlm.nih.gov/38266929/

Jazi, A. N., & Asghar-Ali, A. A. (2020). Obsessive-compulsive disorder in older adults: A comprehensive literature review. Journal of Psychiatric Practice, 26(3), 175–184. https://pubmed.ncbi.nlm.nih.gov/32421289/

Liu, J., Cui, Y., Yu, L., Wen, F., Wang, F., Yan, J., Yan, C., & Li, Y. (2021). Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis. Journal of Child and Adolescent Psychopharmacology, 31(2), 95–101. https://pubmed.ncbi.nlm.nih.gov/33395547/

Mataix-Cols, D., Fernández de la Cruz, L., Nordsletten, A. E., Lenhard, F., Isomura, K., & Simpson, H. B. (2016). Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder. World Psychiatry, 15(1), 80–81. https://pubmed.ncbi.nlm.nih.gov/26833615/

National Institute of Mental Health. (2024). Obsessive-compulsive disorder (OCD). https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd

Öst, L.-G., Andersson, E., Clefberg, L., Fladvad, A., Havnen, A., Riise, E., Wahlund, T., & Wergeland, G. J. (2026). Long-term follow-up of cognitive behavior therapy for obsessive-compulsive disorder in adults and children: A systematic review and meta-analysis. Cognitive Behaviour Therapy, 1–23. https://pubmed.ncbi.nlm.nih.gov/42454578/

Perris, F., Cipolla, S., Catapano, P., Sampogna, G., Luciano, M., Giallonardo, V., Del Vecchio, V., Fabrazzo, M., Fiorillo, A., & Catapano, F. (2023). Duration of untreated illness in patients with obsessive-compulsive disorder and its impact on long-term outcome: A systematic review. Journal of Personalized Medicine, 13(10), 1453. https://pubmed.ncbi.nlm.nih.gov/37888064/

Sharma, E., Thennarasu, K., & Janardhan Reddy, Y. C. (2014). Long-term outcome of obsessive-compulsive disorder in adults: A meta-analysis. Journal of Clinical Psychiatry, 75(9), 1019–1027. https://pubmed.ncbi.nlm.nih.gov/25295427/

Van Ameringen, M., Fineberg, N. A., Ravindran, A., Arnold, P. D., Beaulieu, S., Brakoulias, V., et al. (2026). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder. Journal of Psychiatric Research, 199, 404–488. https://pubmed.ncbi.nlm.nih.gov/42441734/